MétaCan
Menu
← Back to cohort
Record W4299589006 · doi:10.46692/9781847421043.010

Avoiding mixed messages: HPV vaccines and the ‘cure’ for cervical cancer

2009· other· en· W4299589006 on OpenAlexaboutno aff
Alison Hann, Stephen Peckham

Bibliographic record

Venuenot available
Typeother
Languageen
FieldMedicine
TopicCervical Cancer and HPV Research
Canadian institutionsnot available
Fundersnot available
KeywordsCervical cancerMedicineMixed tumorVirologyCancerInternal medicineImmunology

Abstract

fetched live from OpenAlex

Most vaccination programmes are concerned with reducing the prevalence and incidence of a particular infectious disease, such as TB or smallpox. The human papillomavirus (HPV) vaccine, however, is a vaccine that is designed to prevent the development of cervical cancer by protecting the individual against infection by HPV. This chapter examines the evidence base for the policy of a HPV vaccination programme, and suggests that the way in which this information is communicated to the public is loaded and that, furthermore, it may have serious consequences for the screening programme that could, arguably, be counterproductive. Introduction In the autumn of 2008 the UK government commenced the first wave of HPV vaccinations as part of a national programme aimed at 12- and 13-year-old girls. This is to be supplemented with a programme aimed at 18-year-old women. The instigation of the UK programme follows the lead of other countries – specifically the US and Canada – as part of a campaign to tackle cervical cancer. Since the announcement that the UK's Joint Committee on Vaccination and Immunisations recommended a vaccination programme, there has been extensive media coverage aimed at promoting the vaccine in the UK. While the programme is voluntary, it is being undertaken in secondary schools and there is substantial pressure on parents through media reports, celebrity endorsement and TV advertising to agree to the vaccination of their daughters. It is assumed that there is universal support for the vaccine and programme and it is being promoted as the cure for cervical cancer. However, such an approach mixes a number of key public health issues related to the purpose of the programme, who is being given protection, the interaction between different public health programmes and so on, that place public health practitioners and others involved in health promotion and public health in a difficult position. While the HPV vaccine offers some hope of reducing the levels of cervical cancer, concerns have been expressed about its efficacy and the usefulness of the vaccination programme. This is an issue particularly with regard to long-term effects and side effects, and there is concern over the fact that it only protects against four out of the 200 HPV types. For this reason the vaccine does not confer 100% protection and there is still a need to have a national screening programme, particularly for older women.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.016
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.015
Threshold uncertainty score0.051

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.016
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0020.004
Scholarly communication0.0070.009
Open science0.0010.004
Research integrity0.0060.006
Insufficient payload (model declined to judge)0.0150.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.358
Teacher spread0.325 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2009
Admission routes1
Has abstractyes

Explore more

Same topicCervical Cancer and HPV Research→French-language works237,207→